CHICAGO, IL--(Marketwire - November 30, 2009) -
Broncus Technologies, Inc., a medical device
company focused on developing and commercializing innovative solutions for
lung diseases, announced today that it is showcasing its LungPoint System
at the Radiologic Society of North America (RSNA) Annual Meeting.
Radiology departments and imaging centers are expected to benefit from this
system. The computer-assisted, image-guided navigation system takes CT
scans and provides multi-dimensional reconstructions of the airway tree and
virtual animations of pathways to targets or lesions, allowing radiologists
to provide much more sophisticated and detailed image reports to referring
chest physicians.
"This is an exciting technology because finding an appropriate route
through the lung airways to distant targets has long been a challenging
aspect of bronchoscopy," explained pulmonologist J. Burr Ross, MD of John
C. Lincoln Hospital in Phoenix. "This system will allow radiologists to
provide much more comprehensive information to referring physicians which
is something pulmonogists and thoracic surgeons will be quite grateful to
have."
The LungPoint system also provides tools for the physician to use in
reviewing the case with the patient. "Patients really appreciate being
able to see exactly the areas in their own lungs that we are concerned
about. Reviewing the images and pathways the system generates helps the
patient understand the procedure they are about to undergo and puts them at
ease," states Dr. Ross.
The system's planning software will help radiologists and imaging centers
provide more comprehensive reports to physicians. "We believe that the
system will allow radiologists to provide more value and increase their
referrals by delivering thorough procedure planning information to lung
specialists," states Cary Cole, President and CEO of Broncus Technologies.
About the LungPoint System
The LungPoint Procedure Planning and Virtual Bronchoscopic Navigation
system is used to plan and guide bronchoscopic procedures such as lung
biopsies and fiducial marker placement. The software gives the physician
tools to look at the lungs and airways in three dimensions, resulting in
more effective treatment planning and execution. During bronchoscopy, the
planned virtual path is compared to the live bronchoscope video images,
indicating to the physician the correct airway to follow for optimal biopsy
accuracy.
About Broncus Technologies, Inc.
Broncus Technologies is a medical technology company focused on developing
and commercializing innovative solutions for lung diseases. With
LungPoint™, physicians plan bronchoscopic procedures and navigate to
locations in the lungs accurately and quickly. Our line of Yield™
catheters are used to obtain tissue samples and detect blood vessels. Our
patented treatment method, Airway Bypass using Exhale® Drug-Eluting
Stents, is being investigated to determine if it can provide the first
minimally-invasive treatment option for homogeneous, or diffuse, emphysema,
the form of the disease experienced by the majority of emphysema patients.
For more information visit www.broncus.com.
Editors Notes
For more information on LungPoint, the EASE Trial or Broncus Technologies,
please contact Meghan Oreste at 617-823-1441 or moreste@comcast.net
Broncus, LungPoint, Yield, and Exhale are trademarks of Broncus
Technologies, Inc.
